Serena Williams’ return to tennis has sparked a conversation about the use of GLP-1 drugs in sports ^10.4%

CBC Listen - 6/12/2026, 12:00 AM

Framing Effect 58.8% - Post Hoc (False Cause) 38.8% - Attempt to Sell a Product or Service 38.8%

This week, tennis legend Serena Wiliams returned to competition for the first time in four years. While away from the sport, Williams became the face of Zepbound, a GLP-1 weight loss drug and her return to tennis has sparked a debate about the use of GLP-1 drugs in sports. Tennis journalist Stephanie Livaudais tells us how the... more

US regulators approve Wegovy pill for weight loss ^80%

One America News Network - By Jonel Aleccia - 12/23/2025, 8:13 AM

By JONEL ALECCIA Updated 4:18 PM PST, December 22, 2025 The U.S. Food and Drug Administration building in Silver Spring, Md., Aug. 2, 2018. (AP Photo/Jacquelyn Martin, File) U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. more

GLP-1 pills are on the way. Here's what to know ^62%

NPR - By Emily Kwong, Sydney Lupkin, Rachel Carlson, Brent Baughman - 12/19/2025, 8:00 AM

Drugmakers have developed pill versions of GLP-1 medicines to treat obesity. You may have heard of Ozempic, and other GLP-1 drugs. They're everywhere. But weekly injections, cost, and insurance complications mean they're not for everyone. That's why there's a lot of excitement around two new pill forms of the drug. more